Dr. Bhusri currently excels as a council member for the American Heart Association

Forrester Lee has been recognized as professor emeritus at the Yale University School of Medicine.

Dr. John Tejeda lends years of expertise to his work with Perspective Health Partners

 Helping Clinicians automate workflows for better patient outcomes

This Mother’s Day and beyond, as cardiologists we care for the fate of all women. The death of a woman during pregnancy, at delivery, or soon after childbirth is an immeasurable tragedy for her family as well as society at large. Urgent action is ...

At this moment in time the pre-pandemic cardiology research agenda needs to be completely reprioritized. There are two broad areas that now take precedence over all existing research concerns. On the one hand, researchers need to achieve a better understanding of the staggering incidence of deferred or delayed treatment of cardiovascular events and conditions as...

Click here to continue reading...

Dr. Bufalino excels as a cardiologist and the medical director for Edward Heart Hospital

Prof. Parmley was the first recipient of the eponymous William W. Parmley Chair in Cardiology Endowment in 2015

Dr. Harrison specializes in interventional cardiology through his work with Harrison Heart, Vein & Vascular Center, Saline Memorial Hospital and Arkansas Amputation Prevention Center

Dr. Kalra is making substantial differences in cardiology through roles with Cleveland Clinic, the Lerner College of Medicine and makeadent.org

Radionuclide imaging of myocardial perfusion, function, and viability has been established for decades and remains a robust, evidence-based and broadly available means for clinical workup and therapeutic guidance in ischemic heart disease. Yet, powerful alternative modalities have emerged for this purpose, and their growth has resulted in increasing competition. But the potential of the tracer principle goes beyond the assessment of physiology and function, towards the interrogation of biology and molecular pathways. This is a unique selling point of radionuclide imaging, which has been under-recognized in cardiovascular medicine until recently. Now, molecular imaging methods for the detection of myocardial infiltration, device infection and cardiovascular inflammation are successfully gaining clinical acceptance. This is further strengthened by the symbiotic quest of cardiac imaging and therapy for an increasing implementation of molecular-targeted procedures, where specific therapeutic interventions require specific diagnostic guidance towards the most suitable candidates. This review will summarize the current advent of clinical cardiovascular molecular imaging and highlight its transformative contribution to the evolution of cardiovascular therapy beyond mechanical interventions and broad "blockbuster" medication, towards a future of novel, individualized molecular targeted and molecular imaging-guided therapies.

Few reports have explored the measurement validity of the relative value unit (RVU) system, particularly in pediatrics. The RVU system, although broadly applied in health care settings, was developed for the adult population and thus may possess unique inadequacies in pediatrics.

We found deficiencies in the ability of the RVU system to capture features of case mix complexity and differences related to age. Additional investigation may be warranted to determine the validity of RVU as a measurement tool in pediatrics. (Read the full article)

COVID-19 has led the ESC to transition its annual congress to a virtual format; ESC 2020 Congress 'Challenging Times, Infinite Possibilities' will run online from August 29 to September 1.

SAGE Publications

Mission Statement: JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.

Interview with Marc S. Sabatine, MD, MPH, author of Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis

Interview with Jeroen J. Bax, MD, PhD, author of Association of Left Ventricular Global Longitudinal Strain With Asymptomatic Severe Aortic Stenosis: Natural Course and Prognostic Value, and James D. Thomas, author of Moving Past Ejection Fraction in Timing of Aortic Stenosis Intervention

Interview with Nehal N. Mehta, MD, MSCE, author of Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis, and Jagat Narula, MD, PhD, author of Inflammation, Superadded Inflammation, and Out-of-Proportion Inflammation in Atherosclerosis

Interview with Suzanne V. Arnold, MD, MHA, author of Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry

Interview with Utibe R Essien, MD, and Daniel E. Singer, MD, authors of Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

Interview with Andreas M. Zeiher, MD, author of Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure, and Peter Libby, MD, author of CHIPping Away at the Pathogenesis of Heart Failure

Interview with Benjamin D. Levine, author of Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery Calcification

Interview with Paul A Heidenreich, MD, MS, author of Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease

Interview with Scott David. Solomon, MD, author of Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study

Interview with Barry H. Greenberg, author of Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial, and Marvin A. Konstam, MD, author of Antithrombotic Therapy in Heart Failure—The Clot Thickens

Interview with Amit Khera, MD, MSc, author of Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors and and Stephen Daniels, MD, author of Screening for Familial Hypercholesterolemia.

Interview with Stephen W. Waldo, MD, author of Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program

Interview with Richard G. Bach, MD, author of Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial, and Antonio M. Gotto, MD DPhil, author of Intensive Lipid Lowering in Elderly Patients

Interview with Paaladinesh Thavendiranathan, MD, MSc, FRCPC, FASE, author of Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis

Interview with Kausik K. Ray, MD, author of Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial, and Maarten JG. Leening, MD, PhD, author of Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide

Interview with Scott David Solomon, MD, and Stephen Yishu Wang, BS, authors of Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities Study, and Edward P. Havranek, MD, author of The Influence of Social and Economic Factors on Heart Disease

Interview with Michael J. Reardon, MD, Martin B. Leon, MD, and Patrick T. O'Gara, MD, authors of Transcatheter Aortic Valve Replacement for Patients at Low Surgical Risk—Selective or Ubiquitous?

Interview with Tsuyoshi Kaneko, MD, and Sameer A Hirji, MD, authors of Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes, and Michael J. Mack, MD, author of Ninety-Day Outcome Assessment After Transcatheter and Surgical Aortic Valve Replacement—Is the Juice Worth the Squeeze?

Interview with Susan Cheng, MD, MPH, author of Sex Differences in Blood Pressure Trajectories Over the Life Course, and Nanette K. Wenger, MD, author of Adverse Cardiovascular Outcomes for Women—Biology, Bias, or Both?

Interview with Aaron L. Baggish, MD, author of Association of Ascending Aortic Dilatation and Long-term Endurance Exercise Among Older Masters-Level Athletes

Interview with Schuyler Jones, MD, and Adrian F Hernandez, MD, MHS, authors of Rationale and Design of the Aspirin Dosing—A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial

Interview with Robert O. Bonow, MD, Patrick T. O'Gara, MD, Clyde W. Yancy, MD, and Gregg C. Fonarow, MD, authors of Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality and Ajay J. Kirtane, MD

Milan ; New York : Springer, 2007